MannKind Corporation is a pharmaceutical company that develops therapies, including for diabetes. Its filings show it lobbied on diabetes care and on Medicare and Medicaid reimbursement rules, and on TRICARE (the military health care program), likely to influence how its products are paid for. It reported hiring Jeffrey J. Kimbell & Associates and filed once in 2026 with no reported spending.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BRETT MEEKS
The latest disclosures for this client.
JEFFREY J. KIMBELL & ASSOCIATES, INC.
Q2JEFFREY J. KIMBELL & ASSOCIATES, INC.
RRThe entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
JEFFREY J. KIMBELL & ASSOCIATES, INC.
DAVID RUDLOFF
JEFFREY J. KIMBELL & ASSOCIATES, INC.
JOHN HERZOG
JEFFREY J. KIMBELL & ASSOCIATES, INC.
JOHN R RAY
JEFFREY J. KIMBELL & ASSOCIATES, INC.
KEITH STUDDARD
JEFFREY J. KIMBELL & ASSOCIATES, INC.
LAURA KEMPER
JEFFREY J. KIMBELL & ASSOCIATES, INC.
mr JEFFREY J KIMBELL
JEFFREY J. KIMBELL & ASSOCIATES, INC.
mr KENNETH LEE HODGE
JEFFREY J. KIMBELL & ASSOCIATES, INC.